Axogen (AXGN) Depreciation & Amortization (CF) (2011 - 2026)

Axogen's (AXGN) quarterly Depreciation & Amortization (CF) came in at $1.6 million in Q1 2026, down 7.18% year-on-year from $1.7 million in Q1 2025, and down 1.78% quarter-over-quarter from $1.6 million in Q4 2025.

Axogen (AXGN) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends

Axogen's Depreciation & Amortization (CF) history runs 16 years deep, the most recent figure standing at $1.6 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 7.18% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $6.5 million, a 2.08% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, up 2.98% from the prior year.
  • Depreciation & Amortization (CF) fell to $1.6 million in Q1 2026 per AXGN's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $1.7 million in Q1 2025 and bottomed at $645000.0 in Q4 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $1.6 million (2023), against an average of $1.3 million.
  • Across the five-year window, Depreciation & Amortization (CF) fell 8.81% in 2022 and jumped 141.55% in 2023, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $645000.0 in 2022, then soared by 141.55% to $1.6 million in 2023, then increased by 5.01% to $1.6 million in 2024, then declined by 0.18% to $1.6 million in 2025, then retreated by 1.78% to $1.6 million in 2026.
  • Per Business Quant, the three latest AXGN Depreciation & Amortization (CF) figures stand at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 381.00 Mn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 120.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 351.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 40.90 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 67.10 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 310.25 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 78.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Axogen 2.05 Bn 1.95 Bn 46.19 Mn 1.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.60 Mn
Mar 31, 2026 1.60 Mn
Dec 31, 2025 1.63 Mn
Dec 31, 2025 1.63 Mn
Sep 30, 2025 1.64 Mn
Sep 30, 2025 1.64 Mn
Jun 30, 2025 1.66 Mn
Jun 30, 2025 1.66 Mn
Mar 31, 2025 1.73 Mn
Mar 31, 2025 1.73 Mn
Dec 31, 2024 1.64 Mn
Dec 31, 2024 1.64 Mn
Sep 30, 2024 1.65 Mn
Sep 30, 2024 1.65 Mn
Jun 30, 2024 1.66 Mn
Jun 30, 2024 1.66 Mn
Mar 31, 2024 1.52 Mn
Mar 31, 2024 1.52 Mn
Dec 31, 2023 1.56 Mn
Dec 31, 2023 1.56 Mn